Login / Signup
Low-dose vemurafenib in hairy cell leukemia patients with active infection.
Jan-Paul Bohn
Andreas Pircher
David Wanner
David Vill
Bernhard Foeger
Dominik Wolf
Michael Steurer
Published in:
American journal of hematology (2019)
Keyphrases
</>
low dose
single cell
acute myeloid leukemia
high dose
cell therapy
bone marrow